Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,387.60 +52.30 0.34%
S&P 500 1,669.16 +2.87 0.17%
Nasdaq 3,502.12 +5.69 0.16%
Ticker Volume Price Price Delta
STOXX 50 2,821.65 -2.85 -0.10%
FTSE 100 6,803.87 +48.24 0.71%
DAX 8,472.20 +16.37 0.19%
Ticker Volume Price Price Delta
Nikkei 15,381.00 +20.21 0.13%
Hang Seng 23,366.40 -126.66 -0.54%
S&P/ASX 200 5,180.06 -28.98 -0.56%
  • Fund Type: SICAV
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: Global

Bellevue Funds Lux - BB Biotech

+ Add to Watchlist

M0U2:GR

209.4300 EUR 2.1200 1.00%

As of 07:50:20 ET on 05/21/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for Bellevue Funds Lux - BB Biotech (M0U2)

Open: 211.6500 High - Low: 211.6500 - 208.4500 Primary Exchange: Frankfurt
Volume: 0 52-Week Range: 140.2400 - 218.8000 Beta vs DAX: 0.5831

ETF Chart for M0U2

No chart data available.
  • M0U2:GR 209.0280
  • 1D
  • 1M
  • 1Y
211.5500
Interactive M0U2 Chart

Previous Close

Fund Profile & Information for M0U2

Bellevue Funds (Lux) - BB Biotech is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests mainly in equities and equity related securities of companies that are directly involved in the biotechnology sector. The focus is on companies that develop, research, and market various technologies and products in this sector.

Inception Date: 2009-03-31 Telephone: 41-44-267-67-00
Managers: DANIEL KOLLER
Web Site: www.bellevuegroup.com

Fundamentals for M0U2

NAV -
Assets (M) (on 2013-05-17) 28.3615
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for M0U2

No dividends reported

Performance for M0U2

1-Month +7.64% 1-Year +48.01%
3-Month +28.64% 3-Year +22.34%
Year To Date +38.59% 5-Year -
Expense Ratio -

Top Fund Holdings for M0U2

Filing Date: 04/30/2013
Name Position Value % of Total
Gilead Sciences Inc 44,976 2,277,585 8.948%
Celgene Corp 18,702 2,208,145 8.676%
Biogen Idec Inc 9,387 2,055,096 8.074%
Regeneron Pharmaceuticals Inc 8,315 1,788,889 7.028%
Vertex Pharmaceuticals Inc 18,371 1,411,260 5.545%
Alexion Pharmaceuticals Inc 10,846 1,062,908 4.176%
Amgen Inc 9,866 1,028,136 4.039%
Onyx Pharmaceuticals Inc 9,017 854,812 3.358%
BioMarin Pharmaceutical Inc 12,831 841,714 3.307%
Medivation Inc 14,946 787,804 3.095%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil